Search

everythinglearnresearchcommunity

for

Search:↓

Both hair transplantation and skin expansion are effective for treating cicatricial alopecia, with the best method depending on the patient's age, alopecia size, and other factors.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

Dermoscopy is a useful, low-cost method for diagnosing various types of hair loss disorders known as Cicatricial Alopecia.

A 6-year-old girl with head lice developed scarring hair loss but improved with treatment.

Dermoscopy helped correctly diagnose a skin condition that was previously misidentified as a different hair loss disease.

Topical gabapentin was safe and effective for treating scalp symptoms and promoting hair regrowth in cicatricial alopecias.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Hair transplantation is safe and effective for permanent hair loss due to scarring, with high patient satisfaction.

Surgical methods for hair loss due to scarring should be chosen based on the size, location, and shape of the area, with most patients seeing good results.

Dense-packing hair grafting is a simple, safe, and effective way to restore hair in people with cicatricial alopecia.

Leukocyte-rich platelet-rich plasma is safe and can potentially help treat scarring hair loss.

A committee was formed to improve hair restoration for certain hair diseases by collecting and analyzing data.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

The article explains how to diagnose and manage certain types of scarring hair loss.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Accurate diagnosis and tailored treatment are crucial for managing complex hair loss conditions.

Elastin staining helps assess late-stage scarring alopecia but is not definitive, and clinical diagnosis is still crucial.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Follicular Unit Transplantation is an effective and safe treatment for hair loss due to scarring.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.

Middle-aged women in Iran are most affected by primary cicatricial alopecia, especially discoid lupus erythematous.